Why Is ALX Oncology Facing Such a Sharp Decline in Stock Value?

January 24, 2025 03:34 AM PST | By Team Kalkine Media

Why Is ALX Oncology Facing Such a Sharp Decline in Stock Value? — Image source: Shutterstock

Stock Performance and Market Data

ALX Oncology's stock opened at a price of $1.63 on a recent trading day. The stock has experienced a significant drop, with a decrease of 9.4% during the session. Over the past year, the stock has fluctuated between a low of $1.19 and a high of $17.83, indicating a notable range in price volatility.

Financial Ratios and Liquidity

The company reports a debt-to-equity ratio of 0.07, suggesting minimal reliance on debt for financing. Its liquidity position appears robust, as demonstrated by the quick ratio and current ratio, both standing at 4.82. This suggests that the company has sufficient short-term assets to cover its liabilities.

Moving Averages

The stock’s 50-day moving average price is recorded at $1.61, while the 200-day moving average stands at $2.43. These moving averages highlight the general trends in the stock’s price over recent months and a longer-term perspective, respectively.

Market Capitalization and Other Metrics

With a market capitalization of approximately $85.97 million, ALX Oncology is classified as a small-cap company. The firm also reports a negative price-to-earnings (PE) ratio of -0.55, reflecting a period of negative earnings. Additionally, the company’s beta is noted to be 0.98, indicating that the stock’s price movements are slightly less volatile than the broader market.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.